Acadian Asset Management’s Werewolf Therapeutics HOWL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66K | Sell |
61,277
-189,399
| -76% | -$204K | ﹤0.01% | 1452 |
|
|
2025
Q1 | $242K | Buy |
250,676
+8,412
| +3% | +$8.12K | ﹤0.01% | 1224 |
|
|
2024
Q4 | $358K | Sell |
242,264
-23,095
| -9% | -$34.1K | ﹤0.01% | 1152 |
|
|
2024
Q3 | $561K | Buy |
265,359
+53,063
| +25% | +$112K | ﹤0.01% | 1057 |
|
|
2024
Q2 | $516K | Buy |
212,296
+39,413
| +23% | +$95.8K | ﹤0.01% | 1190 |
|
|
2024
Q1 | $1.12M | Buy |
172,883
+94,212
| +120% | +$610K | ﹤0.01% | 811 |
|
|
2023
Q4 | $303K | Hold |
78,671
| – | – | ﹤0.01% | 1143 |
|
|
2023
Q3 | $167K | Hold |
78,671
| – | – | ﹤0.01% | 1226 |
|
|
2023
Q2 | $238K | Hold |
78,671
| – | – | ﹤0.01% | 1236 |
|
|
2023
Q1 | $203K | Buy |
78,671
+49,170
| +167% | +$127K | ﹤0.01% | 1253 |
|
|
2022
Q4 | $60K | Buy |
+29,501
| New | +$60K | ﹤0.01% | 1545 |
|